Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments

<div>In vitro MR imaging of GPC3-targeted NPs uptake. (a) T<sub>2</sub> color maps, (b) T2WI MR images, and (c) normalized T<sub>2</sub> signal intensities. All demonstrated the most significant NPs uptake in HepG2 cells in the pretargeting group. PT, pretargeting group; NT, nonpretargeting group.</div>

Contrast Media & Molecular Imaging

fig6

Figure 6

Figure 6: Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments 

Figure 6 | Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments 